×
For best experience we recommend to activate Javascript in your browser.
Retinoblastoma Binding Protein 8 antibody (Ser327)
This anti-Retinoblastoma Binding Protein 8 antibody is a Rabbit Polyclonal antibody detecting Retinoblastoma Binding Protein 8 in ELISA and IHC. Suitable for Human and Mouse.
Quick Overview for Retinoblastoma Binding Protein 8 antibody (Ser327) (ABIN6101308)
Target
See all Retinoblastoma Binding Protein 8 (RBBP8) Antibodies
Retinoblastoma Binding Protein 8 (RBBP8)
Reactivity
All reactivities for Retinoblastoma Binding Protein 8 antibodies
Human, Mouse
Host
All hosts for Retinoblastoma Binding Protein 8 antibodies
Rabbit
Clonality
All clonalities for Retinoblastoma Binding Protein 8 antibodies
Polyclonal
Conjugate
All conjugates for Retinoblastoma Binding Protein 8 antibodies
This Retinoblastoma Binding Protein 8 antibody is un-conjugated
Application
All applications for Retinoblastoma Binding Protein 8 antibodies
ELISA, Immunohistochemistry (IHC)
Product Details anti-Retinoblastoma Binding Protein 8 Antibody
(hide)
Binding Specificity
All epitopes for Retinoblastoma Binding Protein 8 antibodies
Ser327
Purification
Affinity Chromatography
Immunogen
Synthesized peptide derived from human CtIP around the non-phosphorylation site of S327.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C,-80 °C
Storage Comment
Aliquot and store at -20 °C or -80 °C. Avoid repeated freeze/thaw cycles.
Target Details for Retinoblastoma Binding Protein 8
(hide)
Target
Retinoblastoma Binding Protein 8 (RBBP8)
Alternative Name
RBBP8
Gene ID
5932
UniProt
Q99708
Pathways
Cell Division Cycle , DNA Damage Repair
Recently viewed
(hide)
Chat with us , powered by LiveChat